Received: 11 June 2018
Accepted: 25 September 2018
First Online: 28 October 2018
Ethics approval and consent to participate
: As this survey is part of the project vaccination 60+, IRB approval was obtained from the University of Erfurt (No 17/05/29).Informed consent was obtained by the interviewer. Participation could be abandoned at any time.
: Not applicable.
: CF-S receives grants from the German Federal Ministry of Education and Research (BMBF) via the Center for Sepsis Control and Care (CSCC; FKZ: 01EO1002 and 01EO1502). KR is a paid advisor of Adrenomed Henningsdorf/Berlin and is unpaid chair of the Global Sepsis Alliance which received funds for BRAHMS/Thermofisher, CSL Behring, Becton-Dickinson and Biomerieux; he receives grants from BMBF via the Center for Sepsis Control and Care. SE and CB declare that they have no competing interests.The following members of the vaccination60+ Group declare competing interests: C Forstner and MW Pletz are partly supported by a grant from the Federal Ministry of Education and Research KliFo 2.0 (grant number 01KI1501). All other members of the Vaccination 60+ Group have no competing interests to declare.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.